DEF 14A: IB Acquisition Seeks 6-Month Extension for Business Combo

IB Acquisition Corp. is seeking stockholder approval to extend its deadline to complete a business combination by six months, from September 28, 2025, to March 28, 2026.

Summary

• A special meeting of stockholders will be held on September 22, 2025, at 10:00 a.m. Eastern Time, as a completely virtual meeting.
• Stockholders will vote on three proposals: to amend the company's charter to extend the business combination deadline by six months (from September 28, 2025, to March 28, 2026), to amend the Investment Management Trust Agreement to authorize this extension, and to approve an adjournment of the meeting if necessary.
• The record date for stockholders entitled to vote is September 3, 2025, with 15,749,090 shares of common stock issued and outstanding.
• The Board of Directors unanimously recommends voting FOR all proposals.
• Public stockholders have the right to redeem their shares for cash at an anticipated price of approximately $10.59 per share if the extension is approved.
• The company will not proceed with the extension if redemptions cause its net tangible assets to fall below $5,000,001.
• The company has agreed to waive its right to withdraw up to $100,000 of interest accrued on the Trust Account for dissolution expenses if it ultimately liquidates after the extension.

Sentiment

Score: 3

Explanation: The company is seeking an extension because it has failed to complete its primary objective (a business combination) within the initial timeframe, signaling operational challenges and uncertainty. The potential for significant redemptions, delisting risks, and regulatory concerns further dampen sentiment, despite the board's recommendation for the extension.

Positives

• The proposed six-month extension provides additional time for the company to identify and consummate a suitable business combination, potentially avoiding immediate liquidation.
• The Board of Directors unanimously recommends the extension, indicating continued belief in the ability to find a viable deal.
• The company's agreement to waive its right to withdraw up to $100,000 of interest for dissolution expenses, if it liquidates after the extension, could benefit public shareholders by increasing the per-share redemption value.

Negatives

• The company has been unable to complete a business combination within its initial timeframe, necessitating an extension, which signals challenges in the deal-sourcing process.
• There is a risk of significant redemptions by public stockholders, which could substantially reduce the cash available in the Trust Account, potentially hindering the ability to complete a business combination or leading to delisting.
• The 3,243,590 Founder Shares held by the Sponsor, officers, and directors will become worthless if a business combination is not consummated by September 28, 2025, without the extension, creating a potential conflict of interest.
• The company faces potential delisting from Nasdaq if it fails to maintain certain financial, distribution, and stock price levels, especially following stockholder redemptions.
• A 1% U.S. federal excise tax could be imposed on the company in connection with redemptions, which would reduce the cash available for a business combination.

Risks

• There are no assurances that the extension will enable the company to complete a business combination.
• Redemptions by public stockholders could leave the company with insufficient cash to consummate a business combination on commercially acceptable terms, or at all.
• The existence of separate redemption periods for the extension and a business combination vote could exacerbate redemption risks.
• Stockholders may be unable to recover their investment except through sales of shares on the open market, and the share price may be volatile.
• The company could be deemed an investment company for purposes of the Investment Company Act, potentially forcing it to abandon efforts to consummate a business combination and liquidate.
• Nasdaq may delist the company's securities from trading following stockholder redemptions in connection with the extension amendment, limiting investors' ability to transact in securities and subjecting the company to additional trading restrictions.
• If delisted from Nasdaq, the company's securities could be quoted on an over-the-counter market, leading to limited market quotations, reduced liquidity, potential 'penny stock' designation, limited news/analyst coverage, and decreased ability to issue additional securities or obtain financing.
• The company may not be able to complete an initial business combination with a U.S. target company if it is subject to U.S. foreign investment regulations and review by a U.S. government entity like CFIUS, or is ultimately prohibited.
• A 1% U.S. federal excise tax could be imposed on the company in connection with redemptions, reducing the cash available to complete a business combination.

Future Outlook

The company intends to continue its efforts to consummate an initial business combination by the proposed extended deadline of March 28, 2026. It plans to hold another stockholder meeting prior to this date to seek approval for any identified business combination. The Board believes the extension is crucial to avoid liquidation and provide stockholders an opportunity to consider a business combination.

Management Comments

• "We look forward to seeing you virtually on September 22, 2025." Al Lopez, Chief Executive Officer.
• "The purpose of the above proposals is to allow us additional time to complete our initial business combination."
• "The Board currently believes that there will not be sufficient time before September 28, 2025 to complete an initial business combination."
• "Our Board has approved and declared advisable adoption of the Extension Proposal. Our Board unanimously recommends that our stockholders vote FOR the approval of the Extension Proposal."

Industry Context

This filing reflects a common trend in the Special Purpose Acquisition Company (SPAC) industry where companies frequently seek extensions to their initial business combination deadlines due to challenges in identifying and closing suitable deals. The mention of SEC guidance on SPACs potentially being deemed investment companies and the new U.S. federal excise tax on redemptions highlights the increasing regulatory scrutiny and evolving financial landscape impacting SPACs. The need for an extension, coupled with the risk of significant redemptions and potential delisting, underscores the difficulties many SPACs face in delivering on their initial promise to investors.

Corporate Governance

Related Party Transactions

• The Sponsor, I-B Good Works 4, LLC, which is affiliated with the company's executive officers and certain directors, owns 3,243,590 Founder Shares that will expire worthless if a business combination is not consummated by September 28, 2025, without the extension.
• The Sponsor has agreed to indemnify the company to ensure that the proceeds in the Trust Account are not reduced below $10.05 per public share by certain third-party claims, provided such parties have executed waivers.
• None of the company's officers or directors have received any cash compensation for services rendered to the company.
• On February 28, 2024, the Sponsor distributed 1,016,514 founder shares to one of its members, James Michael McCrory.

Stakeholder Impact

• **Shareholders:** Public stockholders face a critical decision to either redeem their shares for cash (approximately $10.59 per share) or hold them, accepting the prolonged uncertainty and risks of potential delisting or ultimate liquidation, in hopes of a future business combination. Founder shareholders' investment is at significant risk if the extension is not approved and no deal is found.
• **Management/Directors:** Their substantial investment in Founder Shares is contingent on the successful completion of a business combination, giving them a strong incentive to secure the extension and find a deal.
• **Creditors:** In the event of liquidation, the company's obligations under Nevada law to provide for claims of creditors would apply, potentially impacting the final distribution to public shareholders.

Next Steps

• Hold a Special Meeting of Stockholders on September 22, 2025, to vote on the proposed extension and related amendments.
• If the extension proposals are approved, the company will file an amendment to its charter with the Nevada Secretary of State.
• Continue efforts to identify and consummate an initial business combination by the new deadline of March 28, 2026.
• Hold another stockholder meeting prior to March 28, 2026, to seek stockholder approval for any proposed business combination.

Key Dates

Recommendation

The company is at a critical juncture, seeking an extension to avoid liquidation. While the board's unanimous recommendation for the extension suggests a continued effort to find a suitable business combination, the inherent risks of SPACs failing to complete deals, potential significant redemptions, and the threat of delisting create considerable uncertainty. Investors who believe in the management's ability to secure a deal within the extended timeframe might hold, but those seeking certainty or concerned about dilution from redemptions might consider redeeming. Given the current state of uncertainty and the need for an extension, a 'hold' recommendation acknowledges both the potential for a future deal and the significant downside risks.

Keywords

SPAC, IB Acquisition Corp, business combination, extension, proxy statement, shareholder vote, redemption rights, Nasdaq delisting, Trust Account, DEF 14A, corporate governance, Al Lopez, Investment Management Trust Agreement, Founder Shares, CFIUS, excise tax